MPM BioImpact LLC

Holdings History for Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM)

Symbol: CGEM on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	9.1%	0%	$79,159,574	7,648,268	0		$10.35	Q4 2025
30 Sep 2025	7.4%	0%	$45,354,229	7,648,268	0		$5.93	Q3 2025
30 Jun 2025	10%	0%	$57,591,458	7,648,268	0		$7.53	Q2 2025
31 Mar 2025	10%	0%	$57,897,389	7,648,268	0		$7.57	Q1 2025
31 Dec 2024	13%	0%	$93,155,904	7,648,268	0		$12.18	Q4 2024
30 Sep 2024	19%	0%	$128,032,006	7,648,268	0		$16.74	Q3 2024
30 Jun 2024	21%	0%	$133,385,794	7,648,268	0		$17.44	Q2 2024
31 Mar 2024	21%	0%	$130,326,487	7,648,268	0		$17.04	Q1 2024
31 Dec 2023	18%	0%	$77,935,851	7,648,268	0		$10.19	Q4 2023
30 Sep 2023	18%	0%	$69,216,825	7,648,268	0		$9.05	Q3 2023
30 Jun 2023	17%	0%	$82,295,364	7,648,268	0		$10.76	Q2 2023
31 Mar 2023	20%	0%	$78,241,782	7,648,268	0		$10.23	Q1 2023
31 Dec 2022	21%	0%	$80,689,227	7,648,268	0		$10.55	Q4 2022
30 Sep 2022	23%	0%	$98,051,000	7,648,268	0		$12.82	Q3 2022
30 Jun 2022	27%	0%	$98,051,000	7,648,268	0		$12.82	Q2 2022
31 Mar 2022	21%	0%	$80,077,000	7,648,268	0		$10.47	Q1 2022
31 Dec 2021	22%	0%	$118,013,000	7,648,268	0		$15.43	Q4 2021
30 Sep 2021	27%	-0.93%	$172,621,000	7,648,268	-265,619	-3.4%	$22.57	Q3 2021
30 Jun 2021	33%	0%	$203,783,000	7,913,887	0		$25.75	Q2 2021
31 Mar 2021	41%	+41%	$329,772,000	7,913,887	+7,913,887	NEW	$41.67	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.